Altimmune's devastating clinical results announced yesterday results in a 38% cataclysm. The decision to stop developing the nasal covid vaccine probably means Altimmune should come out of the Index.
VBI also dropped a full 10% even though its data was relatively good.
Vaxart dropped 9% and OncoSec fell 5%.
With these bad results, the overall index registered a loss of 1.8% on average with 17 falling and 10 gaining ground.
On the positive side, CureVac is regaining some its devastating losses from last week, gaining 9%.
Both PDS and Translate Bio picked up 7%.
No comments:
Post a Comment